清晨好,您是今天最早来到科研通的研友!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您科研之路漫漫前行!

Abstract CT045: Hyleukin-7, a long-acting interleukin-7, increased absolute lymphocyte counts after subcutaneous and intramuscular administration in healthy subjects

作者
Sang Won Lee,Donghoon Choi,Minkyu Heo,Eui‐Cheol Shin,Su‐Hyung Park,So Jeong Kim,Byung Ha Lee,Se Hwan Yang,Young Chul Sung,Howard Lee
出处
期刊:Clinical Trials [SAGE Publishing]
卷期号:: CT045-CT045
标识
DOI:10.1158/1538-7445.sabcs18-ct045
摘要

Higher lymphocyte counts predict lower mortality in patients with various oncologic malignancies. Interleukin-7 (IL-7), a homeostatic cytokine, plays a critical and non-redundant role in developing T-cells and maintaining immune functions after development. IL-7 is a potent T-cell amplifier, thereby contributing to immune reconstitution, which may result in clinical benefits. A randomized, double-blind, placebo-controlled, dose-escalation, Phase I study was conducted to assess the safety, tolerability, pharmacokinetic and biological properties of Hyleukin-7 (human IL-7 fused to hyFcTM) administered subcutaneously (SC) and intramuscularly (IM) to healthy volunteers.Ten subjects randomly received Hyleukin-7 or its matching placebo in an 8:2 ratio in each of three cohorts at 20 and 60 μg/kg SC and 60 μg/kg IM. Dose escalation and switch from SC to IM was determined on 28 days after study drug administration based on the safety and tolerability data. Subjects were followed up to 56 days after dose.Hyleukin-7 was well tolerated and no subject developed cytokine release syndrome. Injection site reactions were the most common treatment-emergent adverse events, which resolved spontaneously without treatment. Hyleukin-7 was slowly but steadily absorbed and its terminal half-life ranged 48-112 hours. Furthermore, Hyleukin-7 increased absolute lymphocyte counts (ALC) in a dose-dependent manner which lasted during the observed period of 56 days after dose. The mean maximum increase in ALC from baseline was seen 3 weeks after dose. IM Hyleukin-7 increased ALC greater than SC Hyleukin-7 did at the same dose (111.4% IM vs. 75.1% SC). In all of the doses, Hyleukin-7 markedly increased the numbers of all peripheral CD4+ and CD8+ lymphocyte subsets (i.e., naïve, EM, CM and TEMRA). These increases are attributed to enhanced expression of Ki-67.SC and IM Hyleukin-7 was safe and well-tolerated in a dose range of 20 to 60 μg/kg in healthy subjects. A single SC and IM dose of Hyleukin-7 increased ALC dose-dependently. The results of this study warrant further investigation of Hyleukin-7 as a potential immune-oncology therapeutics to treat patients with compromised T-cell immunity.Citation Format: Sang Won Lee, Donghoon Choi, MinKyu Heo, Eui-Cheol Shin, Su-Hyung Park, So Jeong Kim, Byung Ha Lee, Se Hwan Yang, Young Chul Sung, Howard Lee. Hyleukin-7, a long-acting interleukin-7, increased absolute lymphocyte counts after subcutaneous and intramuscular administration in healthy subjects [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2019; 2019 Mar 29-Apr 3; Atlanta, GA. Philadelphia (PA): AACR; Cancer Res 2019;79(13 Suppl):Abstract nr CT045.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
DianaLee完成签到 ,获得积分10
2秒前
YYM完成签到 ,获得积分10
5秒前
科研通AI6.2的应助被TingtingGZ采纳,获得10
6秒前
scenery0510完成签到,获得积分10
7秒前
阿甘完成签到,获得积分10
7秒前
10秒前
11秒前
KalEl发布了新的文献求助10
11秒前
闪闪青雪完成签到,获得积分10
15秒前
tuimao发布了新的文献求助20
15秒前
17秒前
20秒前
molihuakai的应助被tuimao采纳,获得10
21秒前
顺利秋天完成签到,获得积分10
21秒前
乐空思的应助被释风采纳,获得100
35秒前
畅快天空完成签到,获得积分10
45秒前
TingtingGZ发布了新的文献求助10
49秒前
过时的行云完成签到,获得积分10
49秒前
physicalpicture完成签到,获得积分10
51秒前
zzahyc完成签到,获得积分10
1分钟前
1分钟前
坚定百褶裙完成签到,获得积分10
1分钟前
和谐的小懒虫完成签到,获得积分10
1分钟前
reset发布了新的文献求助10
1分钟前
1分钟前
KalEl发布了新的文献求助10
1分钟前
他化自在天完成签到,获得积分10
1分钟前
怕黑的夏之完成签到,获得积分10
1分钟前
等待的依波完成签到,获得积分10
1分钟前
17991完成签到,获得积分10
1分钟前
苗苗完成签到,获得积分10
1分钟前
vbnn完成签到 ,获得积分10
2分钟前
2分钟前
忘忧Aquarius完成签到,获得积分0
2分钟前
buqi完成签到,获得积分10
2分钟前
2分钟前
linj完成签到,获得积分10
2分钟前
petrichor完成签到 ,获得积分10
2分钟前
正常糖完成签到 ,获得积分10
2分钟前
独特问梅完成签到,获得积分10
2分钟前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
plantTFDB 508
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8173213
求助须知:如何正确求助?哪些是违规求助? 9565567
关于积分的说明 21780511
捐赠科研通 7767373
什么是DOI,文献DOI怎么找? 3431542
关于科研通互助平台的介绍 2555730
邀请新用户注册赠送积分活动 2476697